Yuyu Pharma (000220) - Total Liabilities

Latest as of September 2025: ₩63.32 Billion KRW ≈ $42.91 Million USD

Based on the latest financial reports, Yuyu Pharma (000220) has total liabilities worth ₩63.32 Billion KRW (≈ $42.91 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 000220 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Yuyu Pharma - Total Liabilities Trend (2011–2024)

This chart illustrates how Yuyu Pharma's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Yuyu Pharma total assets.

Yuyu Pharma Competitors by Total Liabilities

The table below lists competitors of Yuyu Pharma ranked by their total liabilities.

Company	Country	Total Liabilities
Imas Makina Sanayi AS IS:IMASM	Turkey	TL1.62 Billion
Lohakit Metal Public Company Limited BK:LHK	Thailand	฿425.43 Million
Verbrec Ltd AU:VBC	Australia	AU$41.99 Million
Dogusan Boru Sanayi ve Ticaret AS IS:DOGUB	Turkey	TL5.03 Million
Biokarpet S.A. AT:BIOKA	Greece	€145.70 Million
Iodm Ltd AU:IOD	Australia	AU$2.07 Million
Koan Hao Technology Co Ltd TWO:8354	Taiwan	NT$2.10 Billion
HAV GROUP ASA F:6HH	Germany	€568.81 Million

Liability Composition Analysis (2011–2024)

This chart breaks down Yuyu Pharma's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 000220 equity to assets ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.77	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.49	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.31	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Yuyu Pharma's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Yuyu Pharma (2011–2024)

The table below shows the annual total liabilities of Yuyu Pharma from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩72.62 Billion ≈ $49.22 Million	-6.72%
2023-12-31	₩77.86 Billion ≈ $52.76 Million	+8.39%
2022-12-31	₩71.83 Billion ≈ $48.68 Million	+11.71%
2021-12-31	₩64.30 Billion ≈ $43.58 Million	+69.82%
2020-12-31	₩37.86 Billion ≈ $25.66 Million	-19.73%
2019-12-31	₩47.17 Billion ≈ $31.97 Million	-2.44%
2018-12-31	₩48.35 Billion ≈ $32.77 Million	+25.08%
2017-12-31	₩38.66 Billion ≈ $26.20 Million	+17.11%
2016-12-31	₩33.01 Billion ≈ $22.37 Million	+7.88%
2015-12-31	₩30.60 Billion ≈ $20.73 Million	+2.29%
2014-12-31	₩29.91 Billion ≈ $20.27 Million	+24.69%
2013-12-31	₩23.99 Billion ≈ $16.26 Million	+25.08%
2012-12-31	₩19.18 Billion ≈ $13.00 Million	-9.87%
2011-12-31	₩21.28 Billion ≈ $14.42 Million	--

About Yuyu Pharma

KO:000220 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$42.22 Million

₩62.30 Billion KRW

Market Cap Rank

#22630 Global

#1463 in Korea

Share Price

₩3850.00

Change (1 day)

+0.79%

52-Week Range

₩3435.00 - ₩4740.00

All Time High

₩16106.03